Literature DB >> 23929612

Immeasurable glycosylated haemoglobin: a marker for severe haemolysis.

Nidhi Aggarwal1, Anand Kumar Rai, Yizhak Kupfer, Sidney Tessler.   

Abstract

Glycosylated haemoglobin (HbA1c) is a measurement commonly performed in patients with diabetes. Factors causing a change in the life span of the red blood cell (RBC) can affect the measurement of HbA1c. Thus haemolysis is an important factor that may affect the HbA1c level determination. Haemolysis has been shown to cause a falsely low HbA1c. A 62-year-old man with a history of autoimmune haemolytic anaemia was admitted for severe haemolytic anaemia and an Hb of 2.9 g/dL. HbA1c tested during hospitalisation was unrecordable due to the extremely low Hb. The patient was treated with intravenous steroids, immunoglobulin, fluids and RBC transfusions but continued to haemolyse and eventually expired. We emphasise that an extremely low HbA1c level can serve as a marker of haemolysis and an unrecordable HbA1c level may point towards fatal haemolysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929612      PMCID: PMC3762417          DOI: 10.1136/bcr-2013-200307

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Glucose-6-phosphate dehydrogenase deficiency diagnosed in an adolescent with type 1 diabetes mellitus and hemoglobin A1c discordant with blood glucose measurements.

Authors:  Jennifer A Danzig; Joanne T Moser; Pattianne Belfield; Craig A Alter
Journal:  J Pediatr       Date:  2011-01-13       Impact factor: 4.406

Review 2.  Tests of glycemia in diabetes.

Authors:  D E Goldstein; R R Little; R A Lorenz; J I Malone; D Nathan; C M Peterson
Journal:  Diabetes Care       Date:  1995-06       Impact factor: 19.112

3.  Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin.

Authors:  D Kutter; J Thoma
Journal:  Clin Lab       Date:  2006       Impact factor: 1.138

4.  HbA1C - overall glycemia marker and hemolytic anemia indicator.

Authors:  Marica Jandrić Balen; Vesna Lukenda; Ivan Jandrić; Antonija Raguž; Sidbela Zukanović; Blaženka Miškić
Journal:  Med Glas (Zenica)       Date:  2012-08

5.  [Inappropriate low glycated hemoglobin and hemolysis].

Authors:  A Debard; S Charmion; S Ben Ameur; J-B Gaultier; P Cathébras
Journal:  Rev Med Interne       Date:  2008-11-18       Impact factor: 0.728

  5 in total
  3 in total

Review 1.  Hyperglycemia in patients with hematologic malignancies.

Authors:  Sara J Healy; Kathleen M Dungan
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  Glucose-6-Phosphate dehydrogenase deficiency associated hemolysis in a cohort of new onset type 1 diabetes children in Guangdong province, China.

Authors:  Aijing Xu; Minyan Jiang; Wen Zhang; Yunting Lin; Yongxian Shao; Huifen Mei; Jing Cheng; Cuili Liang; Cuiling Li; Xiuzhen Li; Li Liu
Journal:  Diabetol Metab Syndr       Date:  2022-03-21       Impact factor: 3.320

3.  Manifestation of glucose-6-phosphate dehydrogenase deficiency in the wake of new-onset type 1 diabetes mellitus: a case report.

Authors:  Sandhya Govindarajan; Imran Zamir; Sunil Bagewadi; Emily Moore
Journal:  J Med Case Rep       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.